The results showed that CCIs of epithelial tumor cells, cancer-associated fibroblasts, and tumor-associated macrophages through integrin-related and ANXA1–FPR pairs were poor-prognostic CCIs and are potential therapeutic targets. This evidence concerns the gene ANXA1 and neoplasm.